Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 119 entries
Sorted by: Best Match Show Resources per page
[Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen].

Terapevticheskii arkhiv

Efremova NV, Bolotskaya LL, Atarshchikov DS, Bondarenko ON, Ilyin AV, Shestakova MV.
PMID: 26978173
Ter Arkh. 2015;87(10):42-49. doi: 10.17116/terarkh2015871042-49.

AIM: To implement in 2009-2012 the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen in patients with type 1 diabetes mellitus (DM) to evaluate the efficiency and...

Cite
Efremova NV, Bolotskaya LL, Atarshchikov DS, et al. Primenenie analogov insulina cheloveka u patsientov molodogo vozrasta s sakharnym diabetom 1-go tipa: rezul'taty nablyudatel'noi programmy RESULT po primeneniyu insulina glargin (Lantus) v kombinatsii s insulinom glulizin (Apidra) v bazal'no-bolyusnom rezhime. [Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen]. Ter Arkh. 2015;87(10):42-49doi: 10.17116/terarkh2015871042-49.
Efremova, N. V., Bolotskaya, L. L., Atarshchikov, D. S., Bondarenko, O. N., Ilyin, A. V., & Shestakova, M. V. (2015). Primenenie analogov insulina cheloveka u patsientov molodogo vozrasta s sakharnym diabetom 1-go tipa: rezul'taty nablyudatel'noi programmy RESULT po primeneniyu insulina glargin (Lantus) v kombinatsii s insulinom glulizin (Apidra) v bazal'no-bolyusnom rezhime. [Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen]. Terapevticheskii arkhiv, 87(10), 42-49. https://doi.org/10.17116/terarkh2015871042-49
Efremova, N V, et al. "Primenenie analogov insulina cheloveka u patsientov molodogo vozrasta s sakharnym diabetom 1-go tipa: rezul'taty nablyudatel'noi programmy RESULT po primeneniyu insulina glargin (Lantus) v kombinatsii s insulinom glulizin (Apidra) v bazal'no-bolyusnom rezhime." [Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen]. Terapevticheskii arkhiv vol. 87,10 (2015): 42-49. doi: https://doi.org/10.17116/terarkh2015871042-49
Efremova NV, Bolotskaya LL, Atarshchikov DS, Bondarenko ON, Ilyin AV, Shestakova MV. Primenenie analogov insulina cheloveka u patsientov molodogo vozrasta s sakharnym diabetom 1-go tipa: rezul'taty nablyudatel'noi programmy RESULT po primeneniyu insulina glargin (Lantus) v kombinatsii s insulinom glulizin (Apidra) v bazal'no-bolyusnom rezhime. [Use of human insulin analogues in young patients with type 1 diabetes mellitus: Results of the RESULT observational program on the use of insulin glargine (Lantus) in combination with insulin glulisine (Apidra) as a basal-bolus regimen]. Ter Arkh. 2015;87(10):42-49. doi: 10.17116/terarkh2015871042-49. Russian. PMID: 26978173.
Copy Download .nbib Format: NLM
Ln3I5(S2N2)(S2)(THF)10 - a new type of molecular compounds.

Dalton transactions (Cambridge, England : 2003)

Fagin AA, Fukin GK, Cherkasov AV, Shestakov AF, Pushkarev AP, Balashova TV, Maleev AA, Bochkarev MN.
PMID: 26842841
Dalton Trans. 2016 Mar 21;45(11):4558-62. doi: 10.1039/c5dt04742k. Epub 2016 Feb 04.

Unprecedented complexes of the composition Ln3I5(S2N2)(S2)(THF)10 were obtained in the reactions of neodymium and dysprosium iodide-nitrides with sulfur. The inorganic core of the molecules contains the cyclic fragments Ln(μ-S2)Ln, LnSNSN and LnSN. Ten of the fourteen atoms of the...

Cite
Fagin AA, Fukin GK, Cherkasov AV, et al. Ln3I5(S2N2)(S2)(THF)10 - a new type of molecular compounds. Dalton Trans. 2016;45(11):4558-62doi: 10.1039/c5dt04742k.
Fagin, A. A., Fukin, G. K., Cherkasov, A. V., Shestakov, A. F., Pushkarev, A. P., Balashova, T. V., Maleev, A. A., & Bochkarev, M. N. (2016). Ln3I5(S2N2)(S2)(THF)10 - a new type of molecular compounds. Dalton transactions (Cambridge, England : 2003), 45(11), 4558-62. https://doi.org/10.1039/c5dt04742k
Fagin, A A, et al. "Ln3I5(S2N2)(S2)(THF)10 - a new type of molecular compounds." Dalton transactions (Cambridge, England : 2003) vol. 45,11 (2016): 4558-62. doi: https://doi.org/10.1039/c5dt04742k
Fagin AA, Fukin GK, Cherkasov AV, Shestakov AF, Pushkarev AP, Balashova TV, Maleev AA, Bochkarev MN. Ln3I5(S2N2)(S2)(THF)10 - a new type of molecular compounds. Dalton Trans. 2016 Mar 21;45(11):4558-62. doi: 10.1039/c5dt04742k. Epub 2016 Feb 04. PMID: 26842841.
Copy Download .nbib Format: NLM
cis-Thioindigo (TI) - a new ligand with accessible radical anion and dianion states. Strong magnetic coupling in the {[TI-(μ.

Dalton transactions (Cambridge, England : 2003)

Konarev DV, Khasanov SS, Shestakov AF, Fatalov AM, Batov MS, Otsuka A, Yamochi H, Kitagawa H, Lyubovskaya RN.
PMID: 29026897
Dalton Trans. 2017 Oct 24;46(41):14365-14372. doi: 10.1039/c7dt02878d.

Reaction of decamethylchromocene (Cp*

Cite
Konarev DV, Khasanov SS, Shestakov AF, et al. cis-Thioindigo (TI) - a new ligand with accessible radical anion and dianion states. Strong magnetic coupling in the {[TI-(μ. Dalton Trans. 2017;46(41):14365-14372doi: 10.1039/c7dt02878d.
Konarev, D. V., Khasanov, S. S., Shestakov, A. F., Fatalov, A. M., Batov, M. S., Otsuka, A., Yamochi, H., Kitagawa, H., & Lyubovskaya, R. N. (2017). cis-Thioindigo (TI) - a new ligand with accessible radical anion and dianion states. Strong magnetic coupling in the {[TI-(μ. Dalton transactions (Cambridge, England : 2003), 46(41), 14365-14372. https://doi.org/10.1039/c7dt02878d
Konarev, Dmitri V, et al. "cis-Thioindigo (TI) - a new ligand with accessible radical anion and dianion states. Strong magnetic coupling in the {[TI-(μ." Dalton transactions (Cambridge, England : 2003) vol. 46,41 (2017): 14365-14372. doi: https://doi.org/10.1039/c7dt02878d
Konarev DV, Khasanov SS, Shestakov AF, Fatalov AM, Batov MS, Otsuka A, Yamochi H, Kitagawa H, Lyubovskaya RN. cis-Thioindigo (TI) - a new ligand with accessible radical anion and dianion states. Strong magnetic coupling in the {[TI-(μ. Dalton Trans. 2017 Oct 24;46(41):14365-14372. doi: 10.1039/c7dt02878d. PMID: 29026897.
Copy Download .nbib Format: NLM
[Carbohydrate metabolism in patients with acromegaly and Itsenko-Cushing disease].

Terapevticheskii arkhiv

Matchekhina LV, Belaya ZE, Melnichenko GA, Shestakova MV.
PMID: 28635800
Ter Arkh. 2015;87(10):98-104. doi: 10.17116/terarkh2015871098-104.

The relevance of investigating carbohydrate metabolism (CM) in patients with acromegaly and Itsenko-Cushing disease is attributable to frequent glucose metabolic disturbances, on the one hand, and to difficulties in choosing sugar-lowering therapy in these categories of patients, on the...

Cite
Matchekhina LV, Belaya ZE, Melnichenko GA, et al. Uglevodnyĭ obmen u patsientov s akromegalieĭ i bolezn'iu Itsenko-Kushinga. [Carbohydrate metabolism in patients with acromegaly and Itsenko-Cushing disease]. Ter Arkh. 2015;87(10):98-104doi: 10.17116/terarkh2015871098-104.
Matchekhina, L. V., Belaya, Z. E., Melnichenko, G. A., & Shestakova, M. V. (2015). Uglevodnyĭ obmen u patsientov s akromegalieĭ i bolezn'iu Itsenko-Kushinga. [Carbohydrate metabolism in patients with acromegaly and Itsenko-Cushing disease]. Terapevticheskii arkhiv, 87(10), 98-104. https://doi.org/10.17116/terarkh2015871098-104
Matchekhina, L V, et al. "Uglevodnyĭ obmen u patsientov s akromegalieĭ i bolezn'iu Itsenko-Kushinga." [Carbohydrate metabolism in patients with acromegaly and Itsenko-Cushing disease]. Terapevticheskii arkhiv vol. 87,10 (2015): 98-104. doi: https://doi.org/10.17116/terarkh2015871098-104
Matchekhina LV, Belaya ZE, Melnichenko GA, Shestakova MV. Uglevodnyĭ obmen u patsientov s akromegalieĭ i bolezn'iu Itsenko-Kushinga. [Carbohydrate metabolism in patients with acromegaly and Itsenko-Cushing disease]. Ter Arkh. 2015;87(10):98-104. doi: 10.17116/terarkh2015871098-104. Russian. PMID: 28635800.
Copy Download .nbib Format: NLM
Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus.

Endocrine connections

Dudinskaya EN, Tkacheva ON, Shestakova MV, Brailova NV, Strazhesko ID, Akasheva DU, Isaykina OY, Sharashkina NV, Kashtanova DA, Boytsov SA.
PMID: 26034119
Endocr Connect. 2015 Sep;4(3):136-43. doi: 10.1530/EC-15-0041. Epub 2015 Jun 01.

It is known that glucose disturbances contribute to micro- and macrovascular complications and vascular aging. Telomere length is considered to be a cellular aging biomarker. It is important to determine the telomere length role in vascular structural and functional...

Cite
Dudinskaya EN, Tkacheva ON, Shestakova MV, et al. Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus. Endocr Connect. 2015;4(3):136-43doi: 10.1530/EC-15-0041.
Dudinskaya, E. N., Tkacheva, O. N., Shestakova, M. V., Brailova, N. V., Strazhesko, I. D., Akasheva, D. U., Isaykina, O. Y., Sharashkina, N. V., Kashtanova, D. A., & Boytsov, S. A. (2015). Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus. Endocrine connections, 4(3), 136-43. https://doi.org/10.1530/EC-15-0041
Dudinskaya, E N, et al. "Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus." Endocrine connections vol. 4,3 (2015): 136-43. doi: https://doi.org/10.1530/EC-15-0041
Dudinskaya EN, Tkacheva ON, Shestakova MV, Brailova NV, Strazhesko ID, Akasheva DU, Isaykina OY, Sharashkina NV, Kashtanova DA, Boytsov SA. Short telomere length is associated with arterial aging in patients with type 2 diabetes mellitus. Endocr Connect. 2015 Sep;4(3):136-43. doi: 10.1530/EC-15-0041. Epub 2015 Jun 01. PMID: 26034119; PMCID: PMC4479064.
Copy Download .nbib Format: NLM
Synthesis and cytotoxicity of silicon and germanium containing pyridine oxime O-ethers.

Bioinorganic chemistry and applications

Abele E, Abele R, Arsenyan P, Shestakova I, Kanepe I, Antonenko I, Popelis J, Lukevics E.
PMID: 18365061
Bioinorg Chem Appl. 2003;299-308. doi: 10.1155/S1565363303000232.

Silicon and germanium containing pyridine aldoxime, ketoxime and amidoxime O-ethers have been prepared using phase transfer catalytic systems oxime alkyl halide solid KOH 18-crown-6 benzene and oxime alkyl halide solid K(2)CO(3) or Cs(2)CO(3) 18-crown-6 toluene. Cytotoxic activity of silicon...

Cite
Abele E, Abele R, Arsenyan P, et al. Synthesis and cytotoxicity of silicon and germanium containing pyridine oxime O-ethers. Bioinorg Chem Appl. 2003;299-308doi: 10.1155/S1565363303000232.
Abele, E., Abele, R., Arsenyan, P., Shestakova, I., Kanepe, I., Antonenko, I., Popelis, J., & Lukevics, E. (2003). Synthesis and cytotoxicity of silicon and germanium containing pyridine oxime O-ethers. Bioinorganic chemistry and applications, 299-308. https://doi.org/10.1155/S1565363303000232
Abele, Edgars, et al. "Synthesis and cytotoxicity of silicon and germanium containing pyridine oxime O-ethers." Bioinorganic chemistry and applications vol. (2003): 299-308. doi: https://doi.org/10.1155/S1565363303000232
Abele E, Abele R, Arsenyan P, Shestakova I, Kanepe I, Antonenko I, Popelis J, Lukevics E. Synthesis and cytotoxicity of silicon and germanium containing pyridine oxime O-ethers. Bioinorg Chem Appl. 2003;299-308. doi: 10.1155/S1565363303000232. PMID: 18365061; PMCID: PMC2267057.
Copy Download .nbib Format: NLM
Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results.

Archives of drug information

Güler S, Sharma SK, Almustafa M, Kim CH, Azar S, Danciulescu R, Shestakova M, Khutsoane D, Bech OM.
PMID: 19684847
Arch Drug Inf. 2009 Jun;2(2):23-33. doi: 10.1111/j.1753-5174.2008.00015.x.

AIMS: This paper presents the treatment outcomes for patients intiated on biphasic insulin aspart 30 (BIAsp 30) treatment: BIAsp 30-only, BIAsp 30 + sulphonylureas (SU), BIAsp 30 + biguanides (BI), BIAsp 30 + SU + BI, BIAsp 30 +...

Cite
Güler S, Sharma SK, Almustafa M, et al. Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results. Arch Drug Inf. 2009;2(2):23-33doi: 10.1111/j.1753-5174.2008.00015.x.
Güler, S., Sharma, S. K., Almustafa, M., Kim, C. H., Azar, S., Danciulescu, R., Shestakova, M., Khutsoane, D., & Bech, O. M. (2009). Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results. Archives of drug information, 2(2), 23-33. https://doi.org/10.1111/j.1753-5174.2008.00015.x
Güler, Serdar, et al. "Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results." Archives of drug information vol. 2,2 (2009): 23-33. doi: https://doi.org/10.1111/j.1753-5174.2008.00015.x
Güler S, Sharma SK, Almustafa M, Kim CH, Azar S, Danciulescu R, Shestakova M, Khutsoane D, Bech OM. Improved Glycaemic Control with Biphasic Insulin Aspart 30 in Type 2 Diabetes Patients Failing Oral Antidiabetic Drugs: PRESENT Study Results. Arch Drug Inf. 2009 Jun;2(2):23-33. doi: 10.1111/j.1753-5174.2008.00015.x. PMID: 19684847; PMCID: PMC2721962.
Copy Download .nbib Format: NLM
Automatic processing of unattended lexical information in visual oddball presentation: neurophysiological evidence.

Frontiers in human neuroscience

Shtyrov Y, Goryainova G, Tugin S, Ossadtchi A, Shestakova A.
PMID: 23950740
Front Hum Neurosci. 2013 Aug 09;7:421. doi: 10.3389/fnhum.2013.00421. eCollection 2013.

Previous electrophysiological studies of automatic language processing revealed early (100-200 ms) reflections of access to lexical characteristics of speech signal using the so-called mismatch negativity (MMN), a negative ERP deflection elicited by infrequent irregularities in unattended repetitive auditory stimulation....

Cite
Shtyrov Y, Goryainova G, Tugin S, et al. Automatic processing of unattended lexical information in visual oddball presentation: neurophysiological evidence. Front Hum Neurosci. 2013;7:421doi: 10.3389/fnhum.2013.00421.
Shtyrov, Y., Goryainova, G., Tugin, S., Ossadtchi, A., & Shestakova, A. (2013). Automatic processing of unattended lexical information in visual oddball presentation: neurophysiological evidence. Frontiers in human neuroscience, 7421. https://doi.org/10.3389/fnhum.2013.00421
Shtyrov, Yury, et al. "Automatic processing of unattended lexical information in visual oddball presentation: neurophysiological evidence." Frontiers in human neuroscience vol. 7 (2013): 421. doi: https://doi.org/10.3389/fnhum.2013.00421
Shtyrov Y, Goryainova G, Tugin S, Ossadtchi A, Shestakova A. Automatic processing of unattended lexical information in visual oddball presentation: neurophysiological evidence. Front Hum Neurosci. 2013 Aug 09;7:421. doi: 10.3389/fnhum.2013.00421. eCollection 2013. PMID: 23950740; PMCID: PMC3738864.
Copy Download .nbib Format: NLM
Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma.

Ophthalmology and therapy

Kuzmin A, Lipatov D, Chistyakov T, Smirnova O, Arbuzova M, Ilin A, Shestakova M, Dedov I.
PMID: 25135700
Ophthalmol Ther. 2013 Jun;2(1):41-51. doi: 10.1007/s40123-013-0014-3. Epub 2013 Jun 01.

INTRODUCTION: The aims of this study were: (1) to investigate the association of vascular endothelial growth factor isoform A (VEGF-A) concentration in the anterior chamber liquid (ACL) with vascular proliferation in patients with diabetic retinopathy (DR) who had undergone...

Cite
Kuzmin A, Lipatov D, Chistyakov T, et al. Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma. Ophthalmol Ther. 2013;2(1):41-51doi: 10.1007/s40123-013-0014-3.
Kuzmin, A., Lipatov, D., Chistyakov, T., Smirnova, O., Arbuzova, M., Ilin, A., Shestakova, M., & Dedov, I. (2013). Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma. Ophthalmology and therapy, 2(1), 41-51. https://doi.org/10.1007/s40123-013-0014-3
Kuzmin, Anatoly, et al. "Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma." Ophthalmology and therapy vol. 2,1 (2013): 41-51. doi: https://doi.org/10.1007/s40123-013-0014-3
Kuzmin A, Lipatov D, Chistyakov T, Smirnova O, Arbuzova M, Ilin A, Shestakova M, Dedov I. Vascular endothelial growth factor in anterior chamber liquid patients with diabetic retinopathy, cataract and neovascular glaucoma. Ophthalmol Ther. 2013 Jun;2(1):41-51. doi: 10.1007/s40123-013-0014-3. Epub 2013 Jun 01. PMID: 25135700; PMCID: PMC4108152.
Copy Download .nbib Format: NLM
Heart transplantation in the treatment of primary non-operable cardiac tumors.

Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery

Andrushchuk UU, Ostrovsky YP, Valentsiukevich AV, Shestakova LG, Amelchanka SG, Krutau VG, Yudina OA, Chernoglaz PF, Grinchuk II, Smalenski A.
PMID: 29354182
Kardiochir Torakochirurgia Pol. 2017 Dec;14(4):271-279. doi: 10.5114/kitp.2017.72234. Epub 2017 Dec 20.

No abstract available.

Cite
Andrushchuk UU, Ostrovsky YP, Valentsiukevich AV, et al. Heart transplantation in the treatment of primary non-operable cardiac tumors. Kardiochir Torakochirurgia Pol. 2017;14(4):271-279doi: 10.5114/kitp.2017.72234.
Andrushchuk, U. U., Ostrovsky, Y. P., Valentsiukevich, A. V., Shestakova, L. G., Amelchanka, S. G., Krutau, V. G., Yudina, O. A., Chernoglaz, P. F., Grinchuk, I. I., & Smalenski, A. (2017). Heart transplantation in the treatment of primary non-operable cardiac tumors. Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery, 14(4), 271-279. https://doi.org/10.5114/kitp.2017.72234
Andrushchuk, Uladzimir U, et al. "Heart transplantation in the treatment of primary non-operable cardiac tumors." Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery vol. 14,4 (2017): 271-279. doi: https://doi.org/10.5114/kitp.2017.72234
Andrushchuk UU, Ostrovsky YP, Valentsiukevich AV, Shestakova LG, Amelchanka SG, Krutau VG, Yudina OA, Chernoglaz PF, Grinchuk II, Smalenski A. Heart transplantation in the treatment of primary non-operable cardiac tumors. Kardiochir Torakochirurgia Pol. 2017 Dec;14(4):271-279. doi: 10.5114/kitp.2017.72234. Epub 2017 Dec 20. PMID: 29354182; PMCID: PMC5767780.
Copy Download .nbib Format: NLM
Interligand Charge Transfer in a Complex of Deprotonated cis-Indigo Dianions and Tin(II) Phthalocyanine Radical Anions with Cp*Ir.

Inorganic chemistry

Konarev DV, Zorina LV, Khasanov SS, Shestakov AF, Fatalov AM, Otsuka A, Yamochi H, Kitagawa H, Lyubovskaya RN.
PMID: 29278502
Inorg Chem. 2018 Jan 16;57(2):583-589. doi: 10.1021/acs.inorgchem.7b02351. Epub 2017 Dec 26.

A diamagnetic complex, {(cis-indigo-N,N)

Cite
Konarev DV, Zorina LV, Khasanov SS, et al. Interligand Charge Transfer in a Complex of Deprotonated cis-Indigo Dianions and Tin(II) Phthalocyanine Radical Anions with Cp*Ir. Inorg Chem. 2017;57(2):583-589doi: 10.1021/acs.inorgchem.7b02351.
Konarev, D. V., Zorina, L. V., Khasanov, S. S., Shestakov, A. F., Fatalov, A. M., Otsuka, A., Yamochi, H., Kitagawa, H., & Lyubovskaya, R. N. (2018). Interligand Charge Transfer in a Complex of Deprotonated cis-Indigo Dianions and Tin(II) Phthalocyanine Radical Anions with Cp*Ir. Inorganic chemistry, 57(2), 583-589. https://doi.org/10.1021/acs.inorgchem.7b02351
Konarev, Dmitri V, et al. "Interligand Charge Transfer in a Complex of Deprotonated cis-Indigo Dianions and Tin(II) Phthalocyanine Radical Anions with Cp*Ir." Inorganic chemistry vol. 57,2 (2018): 583-589. doi: https://doi.org/10.1021/acs.inorgchem.7b02351
Konarev DV, Zorina LV, Khasanov SS, Shestakov AF, Fatalov AM, Otsuka A, Yamochi H, Kitagawa H, Lyubovskaya RN. Interligand Charge Transfer in a Complex of Deprotonated cis-Indigo Dianions and Tin(II) Phthalocyanine Radical Anions with Cp*Ir. Inorg Chem. 2018 Jan 16;57(2):583-589. doi: 10.1021/acs.inorgchem.7b02351. Epub 2017 Dec 26. PMID: 29278502.
Copy Download .nbib Format: NLM
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and .

Toxicology reports

Domracheva I, Muhamadejev R, Petrova M, Liepinsh E, Gulbe A, Shestakova I, Duburs G, Arsenyan P.
PMID: 28962371
Toxicol Rep. 2015 Jan 27;2:377-383. doi: 10.1016/j.toxrep.2015.01.009. eCollection 2015.

Addition of DMPC considerably inhibits the degradation of Carmofur in neutral phosphate buffer solutions and this drug becomes less influenced by pH. Carmofur stabilization at neutral pH caused by DMPC addition for

Cite
Domracheva I, Muhamadejev R, Petrova M, et al. 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and . Toxicol Rep. 2015;2:377-383doi: 10.1016/j.toxrep.2015.01.009.
Domracheva, I., Muhamadejev, R., Petrova, M., Liepinsh, E., Gulbe, A., Shestakova, I., Duburs, G., & Arsenyan, P. (2015). 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and . Toxicology reports, 2377-383. https://doi.org/10.1016/j.toxrep.2015.01.009
Domracheva, Ilona, et al. "1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and ." Toxicology reports vol. 2 (2015): 377-383. doi: https://doi.org/10.1016/j.toxrep.2015.01.009
Domracheva I, Muhamadejev R, Petrova M, Liepinsh E, Gulbe A, Shestakova I, Duburs G, Arsenyan P. 1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) increases Carmofur stability and . Toxicol Rep. 2015 Jan 27;2:377-383. doi: 10.1016/j.toxrep.2015.01.009. eCollection 2015. PMID: 28962371; PMCID: PMC5598257.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 119 entries